Blog Detail
The IN VIVO Blog
http://invivoblog.blogspot.com
News, insight and analysis on the business of the biopharmaceutical industry from the editors of Windhover Information and FDC Reports, publishers of IN VIVO and "The Pink Sheet".
- Added on: Jan 20th, 2009
- Country: United States
- Language: English
- Author: Adam Gordon
- Listed in: Mergers & Acquisitions Health
- Tags: acquisitions biotechnology pharmaceutical mergers alliances dealmaking
Recent Posts
While You Were Reforming
You may have heard this already: The US House of Representatives passed a health care reform bill over the weekend. It was a big victory for House Dems, if more of a squeaker than reform proponents would have liked, and now all eyes are on the Senat...
Biovitrum Creates Rare-Disease Focused Spec Pharma with Swedish Orphan Buy
Sweden’s Biovitrum on November 5 stumped up just over half a billion dollars for compatriot Swedish Orphan, buying itself a tidy additional SEK800 million ($115 million) in revenues, an extended commercial network and a couple of near-term launch o...
DotW: Sesame Street
In case you failed to run a Google search this week, you may not have realized that on Tuesday Nov. 10, Sesame Street turns 40. You gotta admit, the show doesn't look a day over five--and that's without Botox.If you've forgotten how to get to Sesame ...
Corporate VCs Star In Financings Of The Fortnight
Oh, venture capitalists. After Dow Jones released its third quarter investment numbers for venture capital two weeks ago, we decided to mine our database to see if all flavors of vc--traditional and strategic--were equally affected. It wasn't terribl...
Option-Based Deals are Here to Stay
Or at least, they're not just a short-term symptom of a buyers’ market, according to a panel of experienced option-dealers talking at Bio-Europe in Vienna on Monday.And no, this wasn’t just Big Pharma wishful thinking; biotech executives were pip...
Meet ViiV, Pfizer and GSK\'s HIV Venture
Ed Silverman at "The Pink Sheet" Daily is reporting that GSK and Pfizer will formally announce tomorrow some details about their new(ish) HIV joint venture. Like, for example, the new name. (Any similarity to your favorite games console or Intel pro...
